We studied the karyotypes of 10 members of a family in whom hypertrophic cardiomyopathy is segregating as an autosomal dominant trait. In all those affected by the disease, a fragile site on the long arm of chromosome 16 was found, expressed with different frequencies, but the unaffected family members did not show this trait.
cardiomyopathies. Boyd et all suggested that there may be three types, one of which is predominantly hypertrophic. Both familial and sporadic forms of hypertrophic cardiomyopathy (HC) have been described in early reports based primarily on medical history and clinical examination. However, -a significant frequency of familial HC, together with a marked variability of expression, were shown in the study of Clark et al,2 who were among the first investigators to use echocardiography to screen relatives of patients with clinically overt HC. Moreover, the true proportion of the sporadic form seems not to be as high as suggested by Maron et al. 3 Some investigators have proposed an autosomal recessive,4 5 and even an X linked recessive,6 mode of transmission, but the most consistent pattern of inheritance seems to be autosomal dominant. Indeed, in the eighth edition of Mendelian inheritance in man7 hypertrophic cardiomyopathy is reported in the section of autosomal dominant phenotypes (* 19260 2) . As can be seen from the pedigree, all the subjects expressing the fragile site are affected by hypertrophic cardiomyopathy with variable morphological and clinical expression. However, the three unaffected subjects who were examined (11.6, III.11, III. 14) did not show the fragile site in any of the 100 metaphases scored for each of them. The fragile site was mostly observed on both chromatids but never on both homologues in the same cell, with frequencies of expression varying from 3% to 16% in different subjects (table) . The analysis of the fragile site breakpoints was performed on elongated chromosomes stained with Chromomycin A3. The breakpoints were located on band q21 at the interface of 16q21 and q22 (fig 3) . When exposed to distamycin A, a great increase in the frequency of expression of the fragile site was observed in the cultures of subjects III.7 and III.9 (table) . The inducibility by distamycin A could suggest the coincidence of this fragile site with the one reported in Human Gene Mapping 916 as 16q22.1 (FRA16B). We can not exclude this possibility. However, in comparison with the normal homologue, it seems to us that the brightly fluorescent band q22 on the fragile chromosome is entirely associated with the part of the chromosome that is distal to the fragile site. Indeed, band q21, localised on the part of the chromosome that is proximal to the fragile site, is a pale fluorescent band. Therefore, the presence of any brightly fluorescent chromatin attached to it would easily be seen, but this was never detected in any of the several metaphases with elongated chromosomes that were analysed. 
